Blue Trust Inc’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
Blue Trust Inc's RGEN Position: Q3 2026 in Review
Blue Trust Inc reduced its Repligen (RGEN) stake by 85% in Q3 2026, selling an estimated $8.46K and leaving 9 shares worth $1.73K. The position accounts for ﹤0.01% of the portfolio, ranked #2070.
Blue Trust Inc first reported a position in RGEN in Q2 2022 and has held it in 17 quarters since. The position peaked at $30.1K in Q3 2024. 220 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.
- Blue Trust Inc held 9 shares of Repligen worth $1.73K as of Q3 2026.
- Blue Trust Inc sold 52 Repligen shares in Q3 2026, an estimated $8.46K.
- Repligen made up ﹤0.01% of Blue Trust Inc's portfolio in Q3 2026, its #2070 holding.
- Blue Trust Inc first reported a position in Repligen in Q2 2022 and has held it in 17 quarters since.
- Blue Trust Inc's Repligen position peaked at $30.1K in Q3 2024.
- 220 funds tracked by Wall St. Rank held Repligen as of Q3 2026.
Based on Blue Trust Inc's 13F filing for Q3 2026, filed 15 Oct 2026.